Case fatality and health care costs in HIV-infected patients: evolution from 1992 to 2000 at Rouen University Hospital, France

被引:8
作者
Basuyau, F [1 ]
Josset, V [1 ]
Merle, V [1 ]
Czernichow, P [1 ]
机构
[1] Univ Rouen, Hop Charles Nicolle, Dept Epidemiol & Publ Hlth, F-76031 Rouen, France
关键词
HIV; AIDS; economics; fatal outcome; HAART;
D O I
10.1258/0956462041944420
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Vital prognosis in HIV-infected patients has been improved by new therapies, leading to an increase in treatment and outpatient costs but lower inpatient care costs. The aim of the study was to compare the health care costs between 1992-1996 (first half) and 1996-2000 (second half) in HIV-infected patients at Rouen University Hospital. Hospitalization costs (including inpatient and outpatient care), infectious complication treatment and antiretroviral therapy costs were evaluated from a National Health Insurance viewpoint. Between 1992 and 2000, 1212 patients were admitted at least once. Total expenditure increased between the two periods from E13,660 to E27,567, i.e., a two-fold increase. During the same period, 125 deaths were avoided, and 3602 years of life were gained. The cost of one avoided death was E108,320 and the cost per life-year gained was E3776.
引用
收藏
页码:679 / 684
页数:6
相关论文
共 24 条
[1]
Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. [J].
Bozzette, SA ;
Joyce, G ;
McCaffrey, DF ;
Leibowitz, AA ;
Morton, SC ;
Berry, SH ;
Rastegar, A ;
Timberlake, D ;
Shapiro, MF ;
Goldman, DP .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :817-823
[2]
CAROSI G, 1998, INTERSCIENCE C ANTIM, V38, P437
[3]
DARIOSECQ JM, 1998, INFECT VIH MEMENTO T
[4]
DELFRAISSY J, 1999, PRISE CHARGE THERAPE
[5]
Delfraissy JF, 2000, PRISE CHARGE THERAPE
[6]
The cost effectiveness of combination antiretroviral therapy for HIV disease. [J].
Freedberg, KA ;
Losina, E ;
Weinstein, MC ;
Paltiel, AD ;
Cohen, CJ ;
Seage, GR ;
Craven, DE ;
Zhang, H ;
Kimmel, AD ;
Goldie, SJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :824-831
[7]
Costs of HIV medical care in the era of highly active antiretroviral therapy [J].
Gebo, KA ;
Chaisson, RE ;
Folkemer, JG ;
Bartlett, JG ;
Moore, RD .
AIDS, 1999, 13 (08) :963-969
[8]
Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs [J].
Holtgrave, DR ;
Pinkerton, SD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1997, 16 (01) :54-62
[9]
JAHNKE N, 1999, AIDS REV, V1, P57
[10]
Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration Hospital [J].
Keiser, P ;
Kvanli, MB ;
Turner, D ;
Reisch, J ;
Smith, JW ;
Nassar, N ;
Gregg, C ;
Skiest, D .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1999, 20 (01) :28-33